Patent · US Active

Silk-based drug delivery system

US8530625B2 · kind B2 · utility

51Cited by
1References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 10, 2012
Grant dateSep 10, 2013
Priority date
Expiry dateApr 10, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/209
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides for novel sustained release silk-based delivery systems. The invention further provides methods for producing such formulations. In general, a silk fibroin solution is combined with a therapeutic agent to form a silk fibroin article. The article is then treated in such a way as to alter its conformation. The change in conformation increases its crytallinity or liquid crystallinity, thus controlling the release of a therapeutic agent from the formulation. This can be accomplished as single material carriers or in a layer-by-layer fashion to load different therapeutic agents or different concentrations of these agents in each layer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.